Moderna Sets Date for Start of Coronavirus Vaccine Phase 3 Trial

Moderna Sets Date for Start of Coronavirus Vaccine Phase 3 Trial

Moderna (NASDAQ: MRNA) has a start date -- at least an approximate one -- for the phase 3 clinical trial of its mRNA-1273 coronavirus vaccine candidate. The highly anticipated trial's estimated launch is Monday, July 27, according to an entry on the government's tracking web site ClinicalTrials.gov. If the trial launches on time, it would fulfill a promise made by Moderna of a July start.